Sleep Apnea Screening

Sleep Apnea/Hypopnea Syndrome Clinical Trial

Official title:
Sleep Apnea-Hypopnea Syndrome Screening

Status Terminated

Clinical Trial Summary

To assess the incidence of Sleep Apnea-Hypopnea Syndrome (SAHS), both obstructive and central, in patients with: 1) pacemaker indication; 2) implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRTD), 3) heart failure and preserved left ventricular ejection fraction (LVEF) and 4) heart failure and reduced LVEF.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Apnea
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Sleep Apnea/Hypopnea Syndrome

Clinical Trial Details

NCT number	NCT02569749
Study type	Observational [Patient Registry]
Source	Arrhythmia Network Technology S.L.
Contact
Status	Terminated
Phase	N/A
Start date	June 2015

View Details

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT02143297` - Automatic Estimation of the Apnea-hypopnea Index Using Neural Networks to Detect Sleep Apnea	N/A